Loading the records…
Loading the records…
HR10094, the Affordable Pricing for Taxpayer-Funded Prescription Drugs Act, was referred to the House Energy and Commerce Committee on August 13, 2026. This early-stage bill targets drug pricing in federal programs, posing a direct bearish signal for pharmaceutical manufacturers ($JNJ, $LLY) and PBM operators ($UNH) through mandated price negotiation.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
The bill is early-stage and partisan, so immediate market reaction is muted. However, it signals ongoing Congressional pressure on drug pricing. $LLY and are the most exposed large-cap pharma due to high Medicare Part D revenue. $UNH's Optum Rx PBM model is also vulnerable to rebate compression. No bullish tickers emerge from this legislation.
What happened: On August 13, 2026, Rep. Val Hoyle (D-OR) introduced HR10094, the Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026. The bill was referred to the House Committee on Energy and Commerce, the primary committee for healthcare legislation. With 7 cosponsors, all Democrats, the bill is in early stage with no committee markup scheduled.
The money trail: The bill authorizes no specific funding — it is a regulatory mandate, not an appropriation. The mechanism forces price negotiation on drugs purchased through Medicare and Medicaid, directly reducing revenue for pharmaceutical companies. The Congressional Budget Office would score this as deficit reduction, not spending.
Convergence: No related signals or procurement data were provided. This bill stands alone as a single legislative signal.
Structural winners and losers: Losers are pharmaceutical companies with high Medicare Part D exposure ($LLY, ) and PBMs that profit from rebate spreads. Winners are taxpayers and federal budget — no public companies benefit directly. The bill's early stage and partisan sponsorship limit near-term market impact.
Timeline: The bill must pass committee markup, House floor vote, Senate companion bill, and Presidential signature. Given the 119th Congress is in its second year, the window for passage narrows. No Senate companion bill exists yet.
Matched on shared policy language across AI analyses, with ticker & timing weight
MERCK SHARP & DOHME LLC: $1.8B Department of Health and Human Services Contract Vehicle
OHIO DEPARTMENT OF MEDICAID: $28.2B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $1.2B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $2.1B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $4.6B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $4.6B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $4.0B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $1.4B Department of Health and Human Services Federal Award
Executive orders & memoranda affecting the same sectors or companies
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →